GT
AGN

Glenview Trust’s Allergan Inc AGN Stock Holding History

Glenview Trust’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		$9.35M Buy
+43,999
New +$8.75M 1% 43

Other funds holding AGN

PSCM
Pershing Square Capital Management New York $13.7B AUM 13.45% 1-Year Est. Return
LTI
Laffer Tengler Investments Nashville, Tennessee $677M AUM 27.58% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Glenview Trust's AGN Position: Q4 2014 in Review

Glenview Trust opened a new position in Allergan Inc (AGN) in Q4 2014: 43,999 shares worth $9.35M. The stake represents 1% of the portfolio and ranks #43 among its holdings.

819 funds tracked by Wall St. Rank hold AGN as of Q4 2014.

  • Glenview Trust held 43,999 shares of Allergan Inc worth $9.35M as of Q4 2014.
  • Allergan Inc was a new Glenview Trust position in Q4 2014.
  • Allergan Inc made up 1% of Glenview Trust's portfolio in Q4 2014, its #43 holding.
  • 819 funds tracked by Wall St. Rank held Allergan Inc as of Q4 2014.

Based on Glenview Trust's 13F filing for Q4 2014, filed 1 May 2017.